Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02033187 · ClinicalTrials.gov registry record · Phase 4
Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients
A Phase 4 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 4
- Development phase
- 12,000
- Enrollment target
NCT02033187: Completed Phase 4 study, sponsored by Vanderbilt University.
NCT02033187 is a Phase 4 study that has completed, run by Vanderbilt University. The registered enrollment target is 12,000 participants, above the 517-participant average among 9,235 other Phase 4 trials with a reported enrollment target (2221% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02033187, a Phase 4 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12,000 participants
- Enrollment target
Study Summary
Healthcare-associated infections are a major cause of morbidity among critically ill patients. Bathing critically ill patients with cloths impregnated with the broad-spectrum antimicrobial agent chlorhexidine-gluconate may decrease healthcare-associated infections. The purpose of this study is to evaluate the effect of daily bathing with disposable chlorhexidine-impregnated bathing cloths, as compared to daily bathing with disposable standard non-chlorhexidine-impregnated bathing cloths, on the rates of healthcare-associated infections in critically-ill patients. Hypothesis: Daily bathing of the skin with chlorhexidine-impregnated bathing cloths will result in reduced rates of healthcare-associated infections in patients admitted to intensive care units (ICU).
Primary Outcome
A composite of the following healthcare-associated infections: 1. Central line-associated blood stream infections (CLABSI) 2. Possible or probable ventilator associated pneumonia (VAP) 3. Catheter-associated urinary tract infection (CAUTI) 4. C. difficile-associated diarrhea
Interventions
- OTHER Chlorhexidine bathing
- OTHER Non-chlorhexidine bathing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,000 participants |
| Start Date | 2012-07 |
| Est. Completion | 2013-07 |
| Phase | Phase 4 |
What the finished NCT02033187 record still lists
NCT02033187 is an interventional study that assigns participants to a tested intervention. Its 12,000 participants enrollment target places it among the larger protocols in the corpus, above the 517-participant average among 9,235 other Phase 4 trials with a reported enrollment target (2221% higher).
The record links to 0 conditions, and to 2 interventions - of which Chlorhexidine bathing is the first listed.
NCT02033187 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02033187 about?
NCT02033187 is a clinical study titled "Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients". Healthcare-associated infections are a major cause of morbidity among critically ill patients. Bathing critically ill patients with cloths impregnated with the broad-spectrum antimicrobial agent chlorhexidine-gluconate may decrease healthcare-associated infections. The purpose of this study is to ev...
What is the current status of trial NCT02033187?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12,000 participants. The study started on 2012-07. Estimated completion is 2013-07.
What interventions are being tested in trial NCT02033187?
The interventions under investigation include: Chlorhexidine bathing (OTHER), Non-chlorhexidine bathing (OTHER).
Who is sponsoring clinical trial NCT02033187?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02033187's enrollment target sits among peer trials
12,000 7th of 2000 higher than 1,994 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01772771 · 12,000 participants
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
- NCT04937868 · 12,000 participants
Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients
- NCT06059963 · 12,000 participants
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
- NCT06273618 · 12,000 participants · NA
iLookOut Micro-learning to Improve Knowledge Retention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia